Lung cancer immunotherapy: progress, pitfalls, and promises

A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …

Recent advances in non-small cell lung cancer targeted therapy; an update review

M Araghi, R Mannani, A Heidarnejad maleki… - Cancer cell …, 2023 - Springer
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …

Non‐small cell lung cancer in China

P Chen, Y Liu, Y Wen, C Zhou - Cancer Communications, 2022 - Wiley Online Library
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors
for lung cancer include tobacco use, family history, radiation exposure, and the presence of …

Genomic–transcriptomic evolution in lung cancer and metastasis

C Martínez-Ruiz, JRM Black, C Puttick, MS Hill… - Nature, 2023 - nature.com
Intratumour heterogeneity (ITH) fuels lung cancer evolution, which leads to immune evasion
and resistance to therapy. Here, using paired whole-exome and RNA sequencing data, we …

Epidemiology of lung cancer

KC Thandra, A Barsouk, K Saginala, JS Aluru… - Contemporary …, 2021 - termedia.pl
Lung cancer is the leading cause of global cancer incidence and mortality, accounting for an
estimated 2 million diagnoses and 1.8 million deaths. Neoplasms of the lungs are the …

Small-cell lung cancer

CM Rudin, E Brambilla, C Faivre-Finn… - Nature Reviews Disease …, 2021 - nature.com
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …

Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force

DE Jonas, DS Reuland, SM Reddy, M Nagle, SD Clark… - Jama, 2021 - jamanetwork.com
Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

[HTML][HTML] Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment

Y Alduais, H Zhang, F Fan, J Chen, B Chen - Medicine, 2023 - journals.lww.com
Lung cancer remains the leading cause of cancer deaths. Non-small cell lung cancer
(NSCLC) is the most frequent subtype of lung cancer. Surgery, radiation, chemotherapy …

Lung cancer 2020: epidemiology, etiology, and prevention

BC Bade, CSD Cruz - Clinics in chest medicine, 2020 - chestmed.theclinics.com
Notable changes in lung cancer epidemiology and prevention have occurred over the past
decade owing to changes in smoking patterns, groundbreaking advances in our …

Derivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learning

Y Lee, JH Park, S Oh, K Shin, J Sun, M Jung… - Nature Biomedical …, 2022 - nature.com
Methods of computational pathology applied to the analysis of whole-slide images (WSIs) do
not typically consider histopathological features from the tumour microenvironment. Here …